Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included increased demand for long-acting contraception since President Trump took office; a payer decision on an insulin pump alarmed diabetes advocates; and despite being involved in cancer treatment decisions, many primary care providers don't feel prepared to do so.

Read more about the stories in this podcast:

Demand for Long-Acting Contraception Increased in Wake of Concerns About Birth Control Access: https://www.ajmc.com/focus-of-the-week/demand-for-longacting-contraception-increased-in-wake-of-concerns-about-birth-control-access

JDRF Alarmed by Extension of UnitedHealthcare-Medtronic Pact to Youth With Type 1 Diabetes: https://www.ajmc.com/focus-of-the-week/jdrf-alarmed-by-extension-of-unitedhealthcaremedtronic-pact-to-youth-with-type1diabetes

Despite Being Involved in Cancer Treatment Decisions, PCPs Lack Knowledge, Confidence: https://www.ajmc.com/focus-of-the-week/despite-being-involved-in-cancer-treatment-decisions-pcps-lack-knowledge-confidence

Examining New Payment Ideas for Curative Therapies: https://www.ajmc.com/newsroom/examining-new-payment-ideas-for-curative-therapies

Evidence-Based Oncology - February 2019: https://www.ajmc.com/journals/evidence-based-oncology/2019/february-2019

Rutgers' Janice Mehnert, MD, on Biomarkers, Being Inclusive in Clinical Trials, and Taking Time to Weigh the Options: https://www.ajmc.com/journals/evidence-based-oncology/2019/february-2019/rutgers-janice-mehnert-md-on-biomarkers-being-inclusive-in-clinical-trials-and-taking-time-to-weigh-the-options

Does Providing Women With Cesarean Delivery Rate Comparison Data Influence Hospital Choice? by Managed Care Cast

Understanding the Scope and Drivers of the Opioid Epidemic by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included President Trump's State of the Union address highlighting healthcare; HHS Secretary Alex Azar taking on drug rebates; physicians asking Congress to fully implement the HITECH Act.

Read more about the stories in this podcast:

Trump Highlights New Initiatives for Childhood Cancer, HIV in State of the Union: https://www.ajmc.com/newsroom/trump-highlights-new-initiatives-for-childhood-cancer-hiv-in-state-of-the-union

Azar Promotes Efforts to Tackle Rebate System: https://www.ajmc.com/conferences/academyhealth-2019/azar-promotes-efforts-to-tackle-rebate-system

AcademyHealth 2019 National Health Policy Conference: https://www.ajmc.com/conferences/academyhealth-2019

Campaign Seeks Push to Improve Usability of EHRs: https://www.ajmc.com/focus-of-the-week/campaign-seeks-push-to-improve-usability-of-ehrs

Getting Ready for the Use of Real-World Evidence: https://www.ajmc.com/focus-of-the-week/getting-ready-for-the-use-of-realworld-evidence

Does Comparing Cesarean Delivery Rates Influence Women’s Choice of Obstetric Hospital? https://www.ajmc.com/journals/issue/2019/2019-vol25-n2/does-comparing-cesarean-delivery-rates-influence-womens-choice-of-obstetric-hospital

Overheard at AcademyHealth: Health Policy, Social Determinants, and Data by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included House and Senate hearings on the cost of prescription drugs; a study finding patients with diabetes can be safely switched to cheaper insulin; and the first non-chemotherapy combination being approved for the treatment of chronic lymphocytic leukemia.

Read more about the stories in this podcast:

Senate Committee Discusses the Burden of High Drug Prices and Potential Solutions: https://www.ajmc.com/newsroom/senate-committee-discusses-the-burden-of-high-drug-prices-and-potential-solutions

Medicare Patients With Type 2 Diabetes Safely Switched From Analog to Human Insulin, JAMA Study Finds: https://www.ajmc.com/newsroom/medicare-patients-with-type-2-diabetes-safely-switched-from-analog-to-human-insulin-ijamai-study-finds

FDA Approves Ibrutinib Combination as Frontline Treatment for CLL: https://www.ajmc.com/newsroom/fda-approves-ibrutinib-combination-as-frontline-treatment-for-cll

What Do Americans Think About Medicare for All? It Depends on What They Hear: https://www.ajmc.com/focus-of-the-week/what-do-americans-think-about-medicare-for-all-it-depends-on-what-they-hear

Congress Doubles Down on High Drug Prices, but Is It More Talk Than Action? https://www.ajmc.com/focus-of-the-week/congress-doubles-down-on-high-drug-prices-but-is-it-more-talk-than-action

The Drug Price Iceberg: More Than Meets the Eye: https://www.ajmc.com/journals/issue/2019/2019-vol25-n2/the-drug-price-iceberg-more-than-meets-the-eye

Discussing the Continuing Decline in Overall Cancer Mortality in the United States by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

​​​​​​​This week, the top managed care news included the Institute for Clinical and Economic Review investigating rising drug prices; CMS expanding value-based insurance design; and researchers using a blood test to detect preclinical Alzheimer disease.

Read more about the stories in this podcast:

What's Driving US Healthcare Costs? Stakeholders Weigh In: https://www.ajmc.com/focus-of-the-week/whats-driving-us-healthcare-costs-stakeholders-weigh-in

ICER Will Review If Drug Price Hikes Are Supported by New Evidence: https://www.ajmc.com/newsroom/icer-will-review-if-drug-price-hikes-are-supported-by-new-evidence

Report: Increasing Drug Prices, Shortages Causing Hospitals to Cut Staff, Putting Patient Safety at Risk: https://www.ajmc.com/focus-of-the-week/report-increasing-drug-prices-shortages-causing-hospitals-to-cut-staff-putting-patient-safety-at-risk

What We're Reading: Insulin Costs Double; PhRMA's Record Spending; Causes of Liver Transplants: https://www.ajmc.com/newsroom/what-were-reading-insulin-costs-double-phrmas-record-spending-causes-of-liver-transplants

CMS Expands VBID in Medicare Advantage, Increases Risk Sharing in Part D: https://www.ajmc.com/newsroom/cms-expands-vbid-in-medicare-advantage-increases-risk-sharing-in-part-d

Researchers Use Blood Test to Detect Preclinical Alzheimer Disease Signs: https://www.ajmc.com/newsroom/researchers-use-blood-test-to-detect-preclinical-alzheimer-disease-signs

Improving Care for Patients With Metastatic Breast Cancer: https://www.ajmc.com/peer-exchange/advances-metastatic-breast-cancer/improving-care-for-patients-with-metastatic-breast-cancer

As Cancer Incidence Changes, so Do Screening Recommendations by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included a new investigation into drug prices; FDA Commissioner Scott Gottlieb, MD, provided updates on how the government shutdown is impacting FDA work; research found comorbidities impede clinical trial participation for patients with cancer.

Read more about the stories in this podcast:

Biologics, Diabetes, Cancer Drugs on House Oversight Probe List: https://www.ajmc.com/newsroom/biologics-diabetes-cancer-drugs-on-house-oversight-probe-list

HHS Medicare Drug Shift Plan Could Reduce Costs Overall but Raise Them for Some, Researchers Say: https://www.ajmc.com/newsroom/hhs-medicare-drug-shift-plan-could-reduce-costs-overall-but-raise-them-for-some-researchers-say

What We're Reading: FDA Resumes Some Inspections; Walmart Leaves CVS' PBM Networks; Flu Season: https://www.ajmc.com/newsroom/what-were-reading-fda-resumes-some-inspections-walmart-leaves-cvss-pbm-networks-flu-season

Comorbidities Impede Clinical Trial Participation Among Patients With Cancer: https://www.ajmc.com/focus-of-the-week/comorbidities-impede-clinical-trial-participation-among-patients-with-cancer

Understanding What Drives Health Information Exchange Use During Postacute Care Transitions: https://www.ajmc.com/managed-care-cast/understanding-what-drives-health-information-exchange-use-during-postacute-care-transitions

The American Journal of Managed Care—January 2019, Health IT Issue: https://www.ajmc.com/journals/issue/2019/2019-vol25-n1